Late Breaking Trials

VENOUS2025 Main Agenda

An open label first in man usability and safety investigation with an intravenous injection technique to deploy tumescence during laser ablation of the great saphenous vein.

Speaker(s)

• MA

  Michael L. Akesson, MD,SCIR

  Senior consultant
  Scandinavian Venous Centre
  Höllviken, Skane Lan, Sweden

Co-Author(s)

• 

  Anders JB Lundell, MD

  Senior consultant
  Scandinavian Venous Centre
  Malmo, Skane Lan, Sweden